According to an expert, Magic mushrooms and LSD could be helpful in treating anxiety and addictions. James Rucker, psychiatrist from King's College London, said that doctors should start recommending the magic mushrooms and LSD to people with anxiety and addictions.

The psychiatrist wrote about the mushroom and LSD in the British Medical Journal. Rucker said the government should think about lowering the unnecessarily restrictive class A and schedule 1 classification of LSD and psilocybin. According to Rucker, the drugs were researched in clinical psychiatry before the ban in 1967.

Rucker said that a number of studies were conducted in the 1950s and 1960s before the ban. The studies suggested a beneficial change in many psychiatric disorders. Research into the effects of psychedelic drugs stopped after 1967. There was belief that psychedelics induce suicidal behavior. The belief was inculcated by the politically driven and media led condemnation of LSD in the 1960s, Rucker added.

According to Rucker, at that time, the drugs were legally classified in the United Kingdom as schedule 1, class A drugs. He said that the psychedelic drugs are more legally restricted than cocaine and heroin. There are not enough proofs which could suggest that psychedelic drugs are habit forming. There is little evidence showing that the drugs are harmful in controlled settings.

Rucker said that there are a number of recent studies which suggested that psychedelics are with clinical efficiency in anxiety linked with advanced cancer and obsessive compulsive disorder. Rucker said, "At present, larger clinical studies on psychedelics are made almost impossible by the practical, financial and bureaucratic obstacles imposed by their schedule 1 classification. Currently, only one manufacturer in the world produces psilocybin for trial purposes".